From: Adherence with tobramycin inhaled solution and health care utilization
AOR* | 95% CI | |
---|---|---|
Overall adherence with TIS | ||
Low (reference) | 1.0 | |
Medium | 0.94 | 0.62-1.41 |
High | 0.40 | 0.19-0.84 |
Age (in years) | ||
<6 (reference) | 1.0 | |
6-10 | 1.76 | 0.89-3.47 |
11-17 | 1.52 | 0.86-2.69 |
18-25 | 1.48 | 0.80-2.73 |
≥26 | 0.73 | 0.38-1.39 |
Gender | ||
Male (reference) | 1.0 | |
Female | 1.04 | 0.74-1.44 |
Comorbidity score | ||
≤Average (reference) | 1.0 | |
>Average | 7.53** | 5.20-10.90 |
Selected comorbidity | ||
Pseudomonas aeruginosa | 3.0** | 2.13-4.32 |
Failure to thrive/growth failure | 2.8** | 1.09-7.14 |